SCHEMBL19919622

SCHEMBL19919622

N#Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C#N)cc4C#N)ccc2n3-c2cc(C#N)c(-c3ccncc3)cc2-n2c3ccc(-c4ccc(C#N)cc4C#N)cc3c3cc(-c4ccc(C#N)cc4C#N)ccc32)c(C#N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.39
XDH P47989 1/20 0.38
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
FLT3 P36888 2/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
CYP19A1 P11511 1/20 0.36
LRRK2 Q5S007 3/20 0.36
PKN1 Q16512 1/20 0.36
PKN2 Q16513 1/20 0.36
MAPK14 Q16539 2/20 0.35
GCGR P47871 1/20 0.35
CSNK1A1 P48729 1/20 0.34
CSNK1D P48730 1/20 0.34
AAK1 Q2M2I8 3/20 0.34
CHEK1 O14757 1/20 0.34
GSK3B P49841 1/20 0.34
MKNK1 Q9BUB5 1/20 0.34
BMP2K Q9NSY1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909006 0.95 STS (0.38) STSXDHCYP11B1CYP11B2FLT3
SCHEMBL19909300 0.93 STS (0.38) STSXDHCYP11B1CYP11B2FLT3
SCHEMBL19909043 0.92 PKN1 (0.39) XDHCYP11B1CYP11B2FLT3CYP19A1
SCHEMBL20923145 0.91 CYP11B1 (0.40) STSXDHCYP11B1CYP11B2FLT3
SCHEMBL19909525 0.91 STS (0.39) STSXDHCYP11B1CYP11B2FLT3
SCHEMBL19908990 0.91 MAPK14 (0.39) XDHCYP11B1CYP11B2FLT3LRRK2
SCHEMBL20923144 0.90 CYP19A1 (0.40) STSXDHCYP11B1CYP11B2FLT3
SCHEMBL20923277 0.90 CYP19A1 (0.40) STSXDHCYP11B1CYP11B2FLT3
SCHEMBL19919765 0.89 STS (0.38) STSXDHCYP11B1CYP11B2FLT3
SCHEMBL19909005 0.88 STS (0.38) STSXDHCYP11B1CYP11B2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 STS 2528/4885XDH 483/4885CYP11B1 610/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 STS 2306/4885XDH 40/4885CYP11B1 1400/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 STS 2528/4885XDH 483/4885CYP11B1 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.